Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma
We describe the recent developments in this field, with emphasis on the complications of therapy and factors contributing to toxicities, efficacy, and resistance. We also describe the ongoing research in this field and the newer CAR-T cell constructs that are being developed to counter the challenges that have been identified in this field.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Clinical Trials | Food and Drug Administration (FDA) | Hodgkin's Disease | Immunotherapy | Leukemia | Lymphoma | Myeloma | Neurology | Non-Hodgkin's Lymphoma | Toxicology | USA Health